| Code |
| RSGK |
| Title |
| PT. Kedoya Adyaraya Tbk |
| Address |
|
| Background |
PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries. |
| Business cp product |
The Company scope of activities is healthcare services. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | % | | Direct Ownership | | | | | PT Daya Guna Usaha | Jakarta | Service and Trading on Health | 99.50 | | PT Sinar Medika Sejahtera | Bekasi | Healthcare services | 90.00 | | PT Sinar Medika Sutera | Tangerang | Healthcare services | 90.00 | | Indirect Ownership | | | | | PT Sinar Medika Farma | Bekasi | Pharmacy | 90.00 |
|
| Commissioners |
| President Commissioner | : Jusup Halimi | | | Commissioner | : Hungkang Sutedja | | | Independent Commissioner | : Murniadi Chandra | | | Independent Commissioner | : dr. Yanto Sandy Tjang | | | | | | Per Sep 30, 2023 | | |
|
| Directors |
| President Director | : dr. Liem Kian Hong | | | Director | : Hendra Munanto | | | Director | : dr. Juniwati Gunawan | | | Director | : Armen Antonius Djan | | | | | | Per Sep 30, 2023 | | |
|
| Underwriter |
| PT. Buana Capital Sekuritas |
|
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT. Bestama Medikacenter InvestamaI | 122,055,540 | 13.13 | | | | PT. Sarana Meditama Metropolitan | 742,242,200 | 79.84 | | | | Hungkang Sutedja | 3,300,000 | 0.35 | | | | Public | 62,077,260 | 6.68 | | | | | | | | | As of Dec 28, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 1,72008-Sep-2021200185,940,000929,675,000
|
| Other infos |
|
| Created date |
| 2024-03-26 13:07:42 |
| Revised date |
| 2024-03-26 15:51:39 |
| Finance |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|